石橋亮一

研究者氏名	石橋亮一
	イシバシリョウイチ
URL
所属	千葉大学
部署	大学院医学研究院内分泌代謝・血液・老年内科学
職名	特任助教
科研費研究者番号	40827549
ORCID ID	0000-0003-2535-5396
J-Global ID	202001003667474243

研究分野

ライフサイエンス / 眼科学 / 糖尿病黄斑浮腫
ライフサイエンス / 代謝、内分泌学 / 糖尿病

論文

12 3 4 5 >

Sodium‐glucose co‐transporter 2 inhibitor therapy reduces the administration frequency of anti‐vascular endothelial growth factor agents in patients with diabetic macular oedema with a history of anti‐vascular endothelial growth factor agent use: A cohort study using the Japanese health insurance claims database

Ryoichi Ishibashi Yosuke Inaba Masaya Koshizaka Yoko Takatsuna Tomoaki Tatsumi Yuki Shiko Yusuke Kashiwagi Yoshiro Maezawa Yohei Kawasaki Eiryo Kawakami Shuichi Yamamoto Koutaro Yokote

Diabetes, Obesity and Metabolism 2024年4月

Imeglimin-mediated glycemic control in maternally inherited deafness and diabetes.

Ryoichi Ishibashi Kiichi Hirayama Suzuka Watanabe Kosuke Okano Yuta Kuroda Yusuke Baba Takuma Kanayama Chiho Ito Keisuke Kasahara Saki Aiba Ryo Iga Ryohei Ohtani Yosuke Inaba Masaya Koshizaka Yoshiro Maezawa Koutaro Yokote

Journal of diabetes investigation 14(12) 1419-1422 2023年12月

Mitochondrial dysfunction causes maternally inherited deafness and diabetes (MIDD). Herein, we report improved glycemic control in a 47-year-old Japanese woman with MIDD using imeglimin without major adverse effects. Biochemical tests and metabolo...

Urinary α1 microglobulin level is useful for selecting sodium-glucose transporter 2 inhibitor or metformin for visceral fat reduction in patients with type 2 diabetes.

Masaya Koshizaka Ryoichi Ishibashi Ko Ishikawa Mayumi Shoji Kana Ide Shintaro Ide Hisaya Kato Naoya Teramoto Ryo Terayama Yoshiro Maezawa Koutaro Yokote

Diabetes, obesity & metabolism 25(10) 3071-3075 2023年10月

Metabolomic analysis of serum samples from a clinical study on ipragliflozin and metformin treatment in Japanese patients with type 2 diabetes: Exploring human metabolites associated with visceral fat reduction.

Ayano Tsukagoshi-Yamaguchi Masaya Koshizaka Ryoichi Ishibashi Ko Ishikawa Takahiro Ishikawa Mayumi Shoji Shintaro Ide Kana Ide Yusuke Baba Ryo Terayama Akiko Hattori Minoru Takemoto Yasuo Ouchi Yoshiro Maezawa Koutaro Yokote

Pharmacotherapy 2023年9月

STUDY OBJECTIVE: The effects of the sodium-dependent glucose transporter-2 inhibitor ipragliflozin were compared with metformin in a previous study, which revealed that ipragliflozin reduced visceral fat content by 12%; however, the underlying mec...

Predictive model and risk engine web application for surgical site infection risk in perioperative patients with type 2 diabetes.

Masaya Koshizaka Ryoichi Ishibashi Yukari Maeda Takahiro Ishikawa Yoshiro Maezawa Minoru Takemoto Koutaro Yokote

Diabetology international 13(4) 657-664 2022年10月

AIM: To identify predictive factors for surgical site infection (SSI) in patients with type 2 diabetes and develop a prediction tool. MATERIALS AND METHODS: We retrospectively analyzed the perioperative blood glucose management of 105 patients wit...